
27 September 2023
Voyager Life plc
("Voyager" or the "Company")
Result of AGM
The Annual General Meeting of the Shareholders of Voyager was held today at 10.00 am (
Full details of the poll results are set out below:
|
Resolution |
For |
Against |
Discretion to Chairman |
Percentage of Voting Rights |
Withheld |
Total |
|
01 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
02 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
03 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
04 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
05 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
06 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
07 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
|
08 |
3,921,073 |
Nil |
Nil |
28.04% |
Nil |
3,921,073 |
The number of shares in issue at 6:30 p.m. (
ENDS
Enquiries:
Voyager
|
Voyager Life plc
Nick Tulloch, CEO
|
Tel: +44 (0) 1738 317 693
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Ludovico Lazzaretti/Liam Murray
|
Tel: +44 (0) 20 7213 0880 |
|
Stanford Capital Partners LLP (Broker)
Patrick Claridge
Bob Pountney |
+44 (0) 203 3650 3650
+44 (0) 203 3650 3651 |
Notes to Editors:
About Voyager
Voyager was founded in 2020 and is based in
The Company's philosophy of plant-based health and wellness is embodied in its mission statement and hashtag of "Choose you". With an experienced team and a product line created in line with the
Through Voyager's bespoke skincare product creation and development division, voyagerCann, the Company also offers a full turnkey service to other CBD, skincare and cosmetics brands assisting them in developing and launching new products with a manufacturing and distribution facility in
Website and social media links:
Voyager:
https://www.instagram.com/voyagercbd/
https://twitter.com/voyagercbd
https://www.linkedin.com/company/voyager-cbd/
https://www.facebook.com/voyagercbd/
voyagerCann:
https://www.instagram.com/voyagercann/
https://twitter.com/voyagercann/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.